Floatz logo

Bisacodyl

Intestinal Cancer

Ospedale Santa Maria delle CrociSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Intestinal Cancer cohort.

Asset / SponsorPhaseRating
MACROGOLS
Ospedale Santa Maria delle Croci
Phase 4BB
SL-28
Second Life Therapeutics
Phase 1/2CCC
Ciprofol
RenJi Hospital
N/AD

Same molecule, other indications

Bisacodyl is also rated in:

Bowel PreparationDormant
B
Indicative ·
60 / 100
View asset →
cirrhosis of liverDormant
CCC
Indicative ·
54 / 100
View asset →
bowel dysfunctionDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →